Olivier Helynck
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4.
Journal: European journal of medicinal chemistry
Published: February 21, 2025
Novel Antiviral Molecules against Ebola Virus Infection.
Journal: International journal of molecular sciences
Published: August 30, 2023
Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands.
Journal: Molecules (Basel, Switzerland)
Published: December 21, 2022
Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism.
Journal: Cell reports
Published: October 01, 2021
SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.
Journal: Nucleic acids research
Published: February 20, 2021
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.
Journal: Nature communications
Published: December 18, 2020
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.
Journal: European journal of immunology
Published: November 07, 2020
First-in-class allosteric inhibitors of bacterial IMPDHs.
Journal: European journal of medicinal chemistry
Published: August 07, 2018
A Novel Polyaminocarboxylate Compound To Treat Murine Pulmonary Aspergillosis by Interfering with Zinc Metabolism.
Journal: Antimicrobial agents and chemotherapy
Published: December 12, 2017
Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis.
Journal: Journal of medicinal chemistry
Published: August 29, 2017
Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.
Journal: Antimicrobial agents and chemotherapy
Published: February 24, 2017
Last Updated: 09/26/2026